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Abstract 
Background 
Methylmercury (MeHg) is an environmental contaminant most known for its severe neurotoxic 
effects. Although accumulation of MeHg tends to be several folds higher in kidney compared to other 
tissues, studies on nephrotoxic effects are almost non-existing. In this study we aim to investigate the 
toxicity of dietary MeHg in kidney of Atlantic salmon (Salmo salar). 
Material and methods 
Atlantic salmon were exposed to dietary MeHg for a period of 8 weeks, before the fish were 
euthanized and kidney was sampled for proteomic and real time RT-PCR analysis, as well as for 
mercury determination. Protein separation was done with 2-D PAGE, and differentially regulated 
spots were picked for analysis using liquid chromatography MS/MS analysis. Moreover, whole blood 
and liver tissue were sampled for mercury determination and real time RT-PCR (liver). 
Results 
MeHg exposed fish accumulated significantly more mercury (Hg) than control fish. The proteomic 
analysis revealed differential abundance of 26 spots in the kidney, and 14 of these protein spots 
were successfully identified. The proteins identified indicated effects of MeHg on; metabolism, 
inflammation, oxidative stress, protein-folding, and cell-structural components. Gene expression 
analysis of selected markers revealed few differentially regulated transcripts in kidney and liver in the 
exposed fish compared to the control fish. However, the affected transcripts indicated a disruption in 
the expression of two metabolic markers due to MeHg exposure in liver. 
Conclusion 
This study suggests that dietary MeHg has similar effects in kidney as previously shown for other 
tissues in fish. The effects observed were in markers for oxidative stress, inflammation and energy 
metabolism. The identification of proteomic markers in this study provides a basis for a better 
understanding of MeHg-induced nephrotoxicity in fish. 
 
Keywords: 
 Methylmercury, kidney, Atlantic salmon, proteomics.  
1. Introduction 
Methylmercury  (MeHg) is an environmental contaminant produced from elemental mercury by 
different sulphate reducing microorganisms (Jensen and Jernelov, 1969). MeHg easily 
bioaccumulates, with consequent biomagnification in the marine food chain, and eventually poses a 
threat to higher trophic layers of fish and mammals through dietary exposure. The LD 50 of MeHg for 
salmonids has been reported to be as high as 15 mg Hg kg-1 in rainbow trout (Onchorhynchus mykiss) 
(Miettinen et al., 1970). However, the effects of MeHg occur at both population and individual level 
at more environmentally relevant doses. Scheuhammer et al (2007) reviewed the environmental 
effects of MeHg on wild fish, and MeHg were shown to affect the reproductive capability. Although 
MeHg shows effects on populations, the molecular responses in individual fish, have been more 
thoroughly studied in order to understand the molecular toxicology of MeHg in fish. High throughput 
analyses, such as microarray and proteomic analyses, have been used to determine biomarkers and 
elucidate toxic modes of action for MeHg in different tissues and species (Berg et al., 2010; Klaper et 
al., 2008; Richter et al., 2011). 
The neurological system has been deemed the main target for MeHg, and neurological effects of 
MeHg have been investigated in different species. A proteomic study investigating MeHg effects in 
the brain of Atlantic cod (Gadus morhua) after intraperitoneal injections revealed effects on 
oxidative stress, cell structural degeneration, calcium homeostasis, and on metabolic markers (Berg 
et al., 2010). Oxidative effects of dietary MeHg in the neurological system have also been observed in 
Atlantic salmon (Berntssen et al., 2003). The toxic response to MeHg is, however, not limited to the 
neurological system. A microarray study performed on acute and chronic intraperitoneally injected 
doses of MeHg in fathead minnow (Pimephales promelas), revealed toxic effects in the liver and 
gonads of the fish (Klaper et al., 2008). Differing effects after acute and chronic exposure in 
adaptation mechanisms to MeHg were also observed, for example in markers for protein processing 
(Klaper et al., 2008). In addition, the up-regulation of apoptotic markers was observed, and was 
suggested as an explanation to the detrimental effects of MeHg on reproduction (Klaper et al., 2008). 
In skeletal muscle of the zebra fish (Danio rerio), MeHg exposure affected mitochondrial energy 
metabolism by inhibiting the coupled ATP oxidative phosphorylation (Bourdineaud et al., 2009). 
Overall, based on current knowledge, MeHg toxicity seems to rely on several molecular mechanisms, 
depending on the tissue studied. However, to our knowledge, no studies have investigated the effect 
of MeHg in fish kidney, even though this organ accumulates among the highest amounts of MeHg in 
salmonids (Berntssen et al., 2003; Boudou and Ribeyre, 1985). In order to investigate mechanisms of 
the renal-response to MeHg contamination, proteomic analysis (2-D PAGE and HPLC MS/MS) was 
used to screen for effects in the kidney of Atlantic salmon exposed to MeHg for eight weeks. For a 
selected set of the identified proteins responding to MeHg exposure, as well as a few additional 
MeHg marker proteins, the transcriptional levels were also determined in the kidney by the means of 
real time RT-PCR. For comparative reasons we investigated the expression of these same genes in the 
liver, as liver tissue is also regarded as central to detoxification. 
 
2. Material and methods 
2.1 Feed production 
Experimental diets were prepared based on a basal fish diets at NOFIMA (Titlestad, Bergen, Norway) 
March 2009. Diet composition per kg was: 505 g fish meal, 60 g wheat gluten, 160 g wheat, 250 g fish 
oil, 20 g vitamin mix, 4 g mineral mix, 0.13 g yttrium oxide, and 0.5 g astaxanthin (Carophyll Pink®). 
To ensure a low level of contaminants (mainly lipid soluble contaminants) in the experimental diets, 
cleaned fish oil was used (FF Skagen, Skagen, Denmark). Two experimental diets were produced; one 
control diet and one enriched with MeHg. The MeHg were added as methylmercury chloride 
(PESTANAL®, Sigma-Aldrich, Seelze, Germany) to a nominal concentration of 4 mg Hg kg-1 feed. The 
final Hg concentrations were determined as 3.8 ± 0.2 mg kg-1 (n = 3) and 0.07 ± 0.01 mg kg-1 (n = 3) in 
the MeHg enriched diet and non-enriched (control) diet, respectively. 
2.2 Feeding trial 
The feeding trial was carried out at NOFIMA Aquaculture Research Station (Austevoll, Norway) 
between March and May 2009. The Atlantic salmon were obtained from Sjøtroll Havbruk AS 
(Bekkjarvik, Norway). The fish (initial weight 564 ± 131 g, n = 18) were randomly distributed to six 
glass fibre tanks (2m × 2m) with 50 individuals in each tank. The tanks were supplied with a 
continuous flow of seawater (80 L/min). The seawater had an average temperature of 9.6 ± 1.0 °C 
during the feeding trial. The fish were kept under continuous light and fed by automatic feeders 
(feeding time: 1400-0300 and 0500-0800). The diets were fed to fish in triplicate tanks for eight 
weeks (54 days). 
2.3 Sampling 
Fish were collected one day after the end of the feeding experiment, and euthanized with a blow to 
the head. The length and weight of the fish were recorded, and blood was drawn from vena caudalis 
into heparinized vials for further Hg analysis and hematocrit measurements. The kidney and liver was 
excised and flash frozen in liquid nitrogen, before they were stored at -80oC for later analysis. 
2.4 Hg analysis 
Total Hg was measured in the kidney and liver samples from each individual fish using atomic 
absorption spectrophotometry (Direct mercury analyzer, DMA-80; Milestone, Sorisole, Italy). The 
accuracy of the analytical methods was assessed by the analysis of two certified reference materials; 
oyster tissue (SMR 1566b; National Institute of Standards and Technology, Gaitersburg, MD, USA; 
certified value 0.0371 ± 0.0013 μg Hg g-1 dry weight) and milk powder (BCR 150; Institute for 
Reference Material and Measurements; Geel, Belgium; certified value 9.4 ± 1.7 ng Hg g-1 dry weight) 
in each analytical run. The values obtained experimentally were in good agreement with the certified 
values 
2.5 Real time RT-PCR 
Total RNA extracted from tissue from both kidney and liver was analyzed using selected genes in real 
time RT-PCR (Table 2). Tissue was homogenized, and total RNA extracted using RNeasy columns 
(Qiagen, Oslo, Norway). The quantity and quality of the RNA was assessed with the NanoDrop ND-
1000 UV-Vis Spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA) and the Agilent 
2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). The Bioanalyzer gave a RNA integrity 
number (RIN) of 9.7 ± 0.1 for kidney (n = 6), and 9.4 ± 0.1 for liver (n = 6). 
The expression of target genes in Atlantic salmon exposed to dietary MeHg, was analyzed using a 
two-step real-time RT-qPCR protocol (Olsvik et al., 2010). The RT reactions were run in triplicates in a 
96 well plate, with 500 ng RNA in each sample. For PCR efficiency calculations a 6-fold serial dilution 
(1000-31 ng) in triplicates, was made from a pooled RNA sample. Template controls (ntc) and RT 
enzyme control (nac) were included in each 384 well plate. The RT reaction was performed according 
to the manufacturer`s instructions using TaqMan® Reverse Transcription Reagents (Applied 
Biosystems, Foster City, CA, USA) on a GeneAmp PCR 9700 machine (Applied Biosystems, Foster City, 
CA, USA).  Reverse transcription was performed at 48°C for 60 min by using oligo dT primers (2.5 μM) 
for all genes in 30 μl total volume. The final concentration of the other chemicals in each RT reaction 
was: MgCl2 (5.5 mM), dNTP (500 mM of each), 10X TaqMan RT buffer (1X), RNase inhibitor (0.4 U/μl) 
and Multiscribe reverse transcriptase (1.67 U μl-1) (Applied Biosystems). Diluted cDNA (1:2) (2.0 μl 
cDNA from each RT reaction) was transferred to a 384-well reaction plate and the qPCR run in 10 μl 
reactions on the LightCycler 480 Real-Time PCR System (Roche Applied Sciences, Basel, Switzerland). 
Real-time PCR was performed by using SYBR Green Master Mix (LightCycler 480 SYBR Green master 
mix kit, Roche Applied Sciences,), which contains FastStart DNA polymerase and gene-specific 
primers (500 nM). PCR was achieved with a 5 min activation and denaturizing step at 95°C, followed 
by 45 cycles of a 15 s denaturing step at 95°C, a 60 s annealing step and a 30 s synthesis step at 72°C. 
Target gene mean normalized expression (MNE) was determined using a normalization factor 
calculated by the geNorm software based on selected reference genes (Vandesompele et al., 2002). 
All genes showed a stable expression both in kidney and liver tissues, i. e. with M-values below 0.5. In 
order to select the most stabile reference genes available, all genes analyzed were checked for 
stability using the geNorm and NormFinder software packages. In kidney it was chosen to use 
elongation factor 1 alpha b (ef1ab) and carnitine palmitoyltransferase 1 (cpt1), as suggested by both 
the geNorm and NormFinder softwares. In liver, nine genes were chosen: B-cell lymphoma X (bclx), 
fatty acid binding protein (fabp), calreticulin (crc), heat shock protein 90 (grp94), tubulin alpha (tuba), 
annexin 13 (anxa13), beta actin (actb), and ef1ab, according to the suggestion by the NormFinder 
software. 
2.6 Protein extraction and gel analysis 
Protein extraction and analysis were performed according to Cash et al (1995). Kidney samples (n=6) 
were homogenized in 2-D Lysis Buffer (0.5 ml 0.5MTris-HCl pH 6.8, 0.125 ml 0.2M EDTA, 12 g Urea, 
2.5 ml 0.5 M DTT, 2.5 ml Glycerol, 1.25 ml NP-40, 3.7 ml pH 3-10 ampholytes, 5 ml MilliQ water) 
using a pestill at room temperature. Lysis buffer was added in a 10:1 ratio. The cell homogenates 
were centrifuged at 11,000 x g for five minutes, and the supernatant was decanted and used for 
further analysis. Proteins from the kidney homogenate were precipitated using ReadyPrepTM 2-D 
Clean kit (Bio-Rad Laboratories, Hercules USA) according to the manufacturer`s instructions.  The 
precipitate was solubilized in IPG Reswell buffer (2.01 g UREA, 0.76 g Thiourea, 0.2 g CHAPS, 0.015 g 
DTT, 3 ml MilliQ water, 50 μl pH 4-7 IPG buffer (GE Healthcare) and sufficient bromophenol blue to 
give the solution a blue colour). The protein solution was sonicated with 3 bursts each of 5 seconds, 
and then incubated with one part DNase solution (0.05 ml 1M MgCl2, 0.5 ml 1 M Tris-HCl pH 8.0, and  
0.1ml 20 000 U ml-1) to two parts protein solution for 10 minutes on ice. 
Protein samples were initially analyzed by 1-Dimensional SDS PAGE to check protein quality and 
determine protein loading for 2D PAGE. Typically, IPG strips (Immobiline™ DryStrip pH 4-7, 7 cm, GE 
Healthcare, Amersham, UK) were rehydrated overnight with 15 μl sample adjusted to a final volume 
of 125μl with IPG reswell buffer. First dimension isoelectric focusing was run on a Multiphor II (GE 
Healthcare) during three steps of different voltage (1 min at 200 V, 1.5 h at 3500 V, and 1 h 5 min at 
3500 V). A ramped change in voltage was applied between steps 2 and 3. Then, the IPG gel strips 
were equilibrated for 30 min in 10 mg ml-1 DTT and subsequently 30 min in 25 mg ml-1 iodoacetamide 
(both prepared in an equilibration stock buffer, 0.05 mg ml-1 Tris, 6 M UREA, 30 % glycerol, and 10 % 
SDS), before they were transferred to the second dimension gels (NuPAGE® Novex 4-12% Bis-Tris 
ZOOM® Gels, IPG Well 1.0 mm, Invitrogen, Paisley, UK). The gels were run in an XCell SureLock™ 
Mini-Cell (Invitrogen, Paisley, UK), at 100 V for 1 h and 200 V for 1.5 h in MOPS running buffer 
(Invitrogen). The gels were fixed (50 % ethanol and 2 % phosphoric acid) over night, before they were 
rinsed in milliQ water and stained with Comassie Brilliant Blue G-250 in an equilibration buffer (68 ml 
methanol, 34 g ammonium sulphate, 4 ml ortophosphoric acid, and milliQ water to 200ml total) for 
up to 4 days. 
The stained gels were scanned wet in an ImageScanner™III (GE Healthcare, UK) with LabScan 
software (GE Healthcare, UK), obtaining 16 bit images, and a resolution of 600 dpi. The images were 
imported into Progenesis SameSpots, version 4.1 (Nonlinear Dynamics, Newcastle upon Tyne, UK). 
For a review on this software see Silva et al. (2010). A reference gel from the control samples was 
chosen, and the remaining gel images were aligned to this. Spots were detected automatically, and 
then reviewed manually using the software. Spots showing a significant difference (p ≤ 0.05) 
between treatments were picked. 
2.7 Protein identification by in gel trypsin digestion 
Following 2-D gel electrophoresis, the protein spots of interest were excised from the gel. Proteins in 
the gel pieces were digested with trypsin (sequencing grade, modified; Promega UK, Southampton, 
UK) using an Investigator ProGest robotic workstation (Genomic Solutions Ltd., Huntingdon, UK). 
Briefly, proteins were reduced with DTT (60°C, 20 min), S-alkylated with iodoacetamide (25°C, 10 
min) then digested with trypsin (37°C, 8 h). The resulting tryptic peptide extract was dried by rotary 
evaporation (SC110 SpeedVac; Savant Instruments, Holbrook, NY, USA) and dissolved in 0.1% formic 
acid for LC-MS/MS analysis. 
2.8 Liquid Chromatography – Tandem Mass Spectrometry (LC-MS/MS) 
Peptide solutions were analysed using an HCTultra PTM Discovery System (Bruker Daltonics Ltd., 
Coventry, UK) coupled to an UltiMate 3000 LC System (Dionex Ltd., Camberley, Surrey, UK). Peptides 
were separated on a Monolithic Capillary Column (200 μm i.d. x 5 cm; Dionex) at a flow rate of 2.5 μl 
min-1 using a gradient of acetonitrile (6 – 38% over 12 min) in 0.04% (aq.) formic acid. Peptide 
fragment mass spectra were acquired in data-dependent AutoMS (2) mode with a scan range of 300 
– 1500 m z-1, 3 averages, and up to 3 precursor ions selected from the MS scan (100 – 2200 m z). 
Precursors were actively excluded within a 1.0 min window, and all singly-charged ions were 
excluded. Peptide peaks were detected and deconvoluted automatically using DataAnalysis software 
(Bruker). Mass lists in the form of Mascot Generic Files were created automatically and used as the 
input for Mascot MS/MS Ions searches of the NCBInr database using the Matrix Science web server 
(www.matrixscience.com). The default search parameters used were: Enzyme = Trypsin; Max. missed 
cleavages = 1; Fixed modifications = Carbamidomethyl (C); Variable modifications = Oxidation (M); 
Peptide tolerance ± 1.5 Da; MS/MS tolerance ± 0.5 Da; Peptide charge = 2+ and 3+; Instrument = ESI-
TRAP. 
2.9 Functional annotation and pathway analysis 
The proteins identified were functionally annotated using www.genecards.com. The letter codes 
obtained from www.genecards.com correspond to mammalian proteins, so additional NCBI blast 
searches were used as confirmation of similarity between the fish protein, and the corresponding 
mammalian protein. The proteins and their fold change were analyzed using “Tox analysis” (limited 
to kidney) in Ingenuity Pathway Analysis (IPA).   
2.10 Statistical analysis 
Differences in the physiological parameters of the fish (weight, length, mortality and hematocrit), 
were analyzed using student t-test (p < 0.05), and presented as mean ± SD.  Mercury analysis and 
gene expression statistics were investigated using Statistica 9 (StatSoft Inc., Tulsa, USA). Differences 
in gene-expression were analyzed using the non-parametric Mann-Whitney U test.  Differences in 
protein spots were detected with one way ANOVA using Progenesis SameSpots. All analyses were 
checked for tank effects using one-way ANOVA, or Kruskal-Wallis. Effects observed in all analyses 
were deemed significant when p < 0.05.     
3. Results 
3.1 MeHg accumulated in tissues, but did not affect physiological parameters of the fish 
MeHg did not significantly affect mortality (no mortality observed), nor growth of the Atlantic salmon 
as measured by final length (43.9 ± 1.9 cm, n = 18) and weight (1240 ± 185 g, n = 18). No significant 
differences were observed in the blood parameter hematocrit (38 ± 8 %, n = 14) of the exposed 
salmon (p < 0.05) compared to control fish.  A significant accumulation of MeHg was seen in plasma, 
red blood cells, liver and kidney of the exposed fish (Table 1). When comparing the accumulation in 
the different tissues, high to low accumulation were observed in the respective order: Red blood cells 
> liver ≈ kidney >> plasma. 
3.2 Dietary MeHg affected proteomic abundances in kidney of salmon 
Protein abundances from kidney samples were compared through 2-D gel analysis using Progenesis 
SameSpots. The gels showed good resolution (fig. 1) and after editing gels for background, 468 spots 
were detected and included in the analysis. From these, 26 spots were significantly regulated (p < 
0.05) in response to MeHg. 18 of these spots were selected for identification using peptide fragment 
fingerprinting and LC MS/MS, and from these 14 were successfully identified (Table 3). All proteins 
identified showed low fold changes, but were all significantly up- or down-regulated. Alpha-1-
antiproteinase-like protein (SERPINA7), hemopexin like protein (HPX), and vacuolar protein sorting 
associated protein 29 (VSP29) were identified in two or three different spots. This was probably due 
to the occurrence of post translational modifications (PTMs) or degradation of the protein, where 
both of these factors can affect protein isoelectric point (PI) or molecular weight. Otherwise, all 
proteins theoretical pI and molecular weights were consistent with the observed electrophoretic 
mobilities by 2D-PAGE. In addition to the aforementioned proteins, the following proteins were 
successfully identified: β-actin (ACTB), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 
glutathione peroxidase 2 (GPX2), heat shock 90 protein 1 β isoform a (Hsp90AB1), 60 kDa heat shock 
protein (HSPD1), galectin 2 (LGALS2) and ATP synthase H+ transporting mitochondrial F1 complex β 
(ATP5B). 
3.3 MeHg showed minor effects on transcriptomic data. 
Proteins identified in this study, and proteins regulated by MeHg and fatty acids in another study 
(Nøstbakken et al., In prep.), were used as a starting point for primer design when investigating the 
transcriptional response of Atlantic salmon kidney and liver to MeHg. These, and certain transcripts 
otherwise known to be affected by MeHg, were analyzed in kidney and liver from the MeHg exposed 
Atlantic salmon and compared to control fish. Due to the relatively small changes observed in gene 
expression, the choice of reference genes was determined after evaluating the stability of all 
analyzed genes. This also affected the range of target genes analyzed in the different tissues. In 
kidney, the following target genes were analyzed: fatty acid binding protein 3 (fabp3), glutathione 
peroxidase 2 (gpx2), acetyl-co-oxidase (aco), aldo-keto reductase 1B3 (akr 1b3), 14-3-3E1, annexin 
A13 (anxa13), glyceraldehyde-3-phosphate dehydrogenase (gapdh), ferritin, tubulin α (tuba), heat 
shock protein 90kDa beta (grp94), calreticulin (crc), B-cell lymphoma X (bclx), warm temperature 
acclimation related 65 kDa protein/hemopexin (wap65), beta actin (actb), actin related protein (arp) 
and ubiqutin (ubi) (Table 4). No significant effects were observed in any of the genes analyzed in 
kidney. In liver, the following target genes were analyzed: fatty acid transport protein (fatp), gpx2, 
ferritin, wap65, gapdh, 14-3-3b1, akr 1b3, aco, and arp (Table 4). In liver aco and gapdh showed a 
significant decreased gene expression in MeHg-exposed fish (p < 0.05) (fig. 2). 
3.4 Pathway analysis 
Proteins differentially regulated by MeHg were analyzed using Ingenuity Pathway Analysis (IPA). 
Pathway analysis incorporated the differentially regulated proteins in a network with a score of 11. 
Proteins in this network is involved in; carbohydrate metabolism, energy production, and, nucleic 
acid metabolism. IPA revealed that the top toxicological pathways associated with MeHg in this study 
were: oxidative stress, increased renal proliferation, hypoxia, gene regulation of Peroxisome 
Proliferator-activated receptor (PPARα), and mitochondrial dysfunctions. Additionally, several 
biological functions were related to the differentially regulated proteins in this study (Supplementary 
data Table).     
4. Discussion 
Few studies have investigated the molecular response induced by MeHg in the kidney of fish, even 
though the kidney accumulates relatively high amount of MeHg in salmonids (Berntssen et al., 2003; 
Boudou and Ribeyre, 1985), even under sub-lethal conditions. A study comparing effects of MeHg on 
oxidative stress and tissue damage in Atlantic salmon parr, revealed more detrimental effects in 
nervous tissue than in kidney and liver, although accumulation of MeHg in kidney and liver were 
higher (Berntssen et al., 2003). Compared to the analyses by Berntsen et al (2003), similar 
accumulation of MeHg in kidney and liver was observed in our study. To further explore MeHg-
induced molecular responses in the Atlantic salmon kidney, we implemented exploratory proteomics 
in our study. MeHg affected proteomic markers involved in oxidative stress, metabolic toxicity, 
inflammation, and protein folding and handling. These effects were similar to those observed in 
other fish studies (Berg et al., 2010; Klaper et al., 2008; Richter et al., 2011), implying that Atlantic 
salmon kidney showed similar modes of toxicity as in other tissues. However, all fold changes in 
protein abundance in our study indicated a lower response in the kidney compared to tissues studied 
in other proteomic studies (Berg et al., 2010). However, some aspect of the low fold changes in 
protein abundance that we observed compared to others may be due to the choice of species, route 
of administration and methodological approaches. In addition to the proteomics data, transcriptional 
changes of selected gene markers were assessed. Transcriptional regulation was in general shown to 
be low in both kidney and liver, which could be attributed to the long term aspect of this study. In 
fact, the transcriptional responses were so marginal that α-tubulin (tuba), a known marker of 
structural degradation caused by MeHg (Crespo-López et al., 2009), was suggested as a reference 
gene by both the geNorm and NormFinder reference gene selection softwares, due to its stabile 
expression. As a result, the main focus in this discussion was based on the proteomic data.     
4.1 Dietary MeHg induce oxidative stress in the kidney 
A well known toxic effect of MeHg is its ability to induce oxidative stress (Aschner et al., 2007; 
Berntssen et al., 2003). The influence of MeHg on the red-ox systems in cells has been largely 
attributed to the production of reactive oxygen species (ROS) (Ni et al., 2010), and/or inhibition of 
antioxidant systems, such as the glutathione system (Gatti et al., 2004). Our proteomic study 
revealed that GPX2 was increased in abundance in the kidney of MeHg- exposed fish compared to 
control fish. This was consistent with findings by Cuello et al. (2010), where an increased activity of 
GPX was observed in the hepatic cell line HepG2, after MeHg exposure. However, several studies 
have reported that GPX-activity is down-regulated in response to MeHg (Franco et al., 2009; Glaser 
et al., 2010). GPXs are a family of enzymes capable of reducing several organic and inorganic 
hydroperoxides, and thereby reducing oxidative stress in cells (Masella et al., 2005). As GPX are 
selenium dependent enzymes (Rotruck et al., 1973), their activity is dependent on the availability of 
selenium. MeHg can post-trancriptionally affect the activity of GPX through the binding of free 
selenium, or direct binding of the active site of GPX thereby blocking its function (Ralston et al., 
2008). The increased protein abundancy of GPX observed in our study may be the kidneys 
transcriptional response to oxidative stress, without necessarily increasing the enzymatic activity of 
GPX. Still, it remains an indication of increased oxidative stress in the kidney. HPX, another marker 
for oxidative stress (Li et al., 2009), was significantly down-regulated in kidney of the MeHg-exposed 
fish. No effect was, however, observed on the transcriptional levels of the warm-temperature-
acclimation-associated protein (wap65), a plasma glycoprotein showing homology to mammalian 
hemopexin (Sarropoulou et al., 2010). The human homologue to fish HPX; hemopexin (HPX) has 
previously been deemed as a biomarker for nephrotoxicity (Thukral et al., 2005). However, the 
faltered protein abundance of fish HPX, may be more indicative of MeHg-induced blood physiological 
changes in the fish. Mammalian HPX is a hematological protein, and probably stems from blood 
within the kidney at the time of excision. The main function of HPX is binding and exporting heme 
from the blood to the liver, clearing the blood of excess iron after hemolysis and recirculation of 
heme for hematopoesis (Tolosano et al., 2010). In a study using hemopexin-deficient mice, an 
increase in iron deposition in the kidney, and consequent nephrotoxicity due to increased oxidative 
stress in the kidney, was observed (Tolosano et al., 1999). In our study red blood cells accumulated 
high amounts of Hg, and MeHg-induced hemolysis of red blood cells with consequent iron deposition 
in the liver may be another mechanism explaining the elevated oxidative stress in the kidney. 
4.2 Dietary MeHg affects energy metabolism 
The production of ROS, and consequent oxidative stress, has been explained as a secondary response 
in MeHg toxicity due to MeHg-induced effects on electron transfer in mitochondrial energy 
metabolism (Yee and Choi, 1996).  There exist several studies showing molecular effects of MeHg on 
metabolic markers (Berg et al., 2010; Cambier et al., 2009; Thukral et al., 2005).  Thukral et al (2005) 
showed a reduced expression of genes associated with β-oxidation, electron transfer, fatty acid 
transport and nitrogen metabolism in the kidney of rats after inorganic Hg exposure. These effects 
were regarded as indicative of renal toxicity since renal secretion is an active process (Thukral et al., 
2005). In our study, ATP5B was down-regulated in MeHg exposed fish. MeHg has been shown to 
inhibit the rate III mitochondrial respiration (ADP- dependent oxidative phosphorylation), but not the 
rate IV mitochondrial respiration in zebra fish skeletal muscle (Bourdineaud et al., 2009). This implies 
that MeHg may inhibit the enzymes responsible for phosphorylation of ATP in the mitochondria, such 
as ATP5B. Moreover, GAPDH, an important catalyst in the energy-yielding step of carbohydrate 
metabolism, was down-regulated in our study, suggesting effects of MeHg on mitochondrial energy 
metabolism. 
Compared to the proteomic data, gene transcriptional analysis revealed few effects of MeHg. In 
kidney, out of a total of 16 genes analyzed, no significant transcriptional response were observed. In 
liver, however, the expression of aco and gapdh were expressed significantly lower in response to 
MeHg. Both genes are involved in energy metabolism, suggesting that MeHg may affect metabolic 
processes at transcriptional and/or post-transcriptional levels. The most noteworthy regarding the 
transcriptomic results, however, was the relatively stable expression observed for most transcripts. 
This indicated that transcriptomic alterations were less suited as biomarkers during long-term MeHg 
exposure than responses at the protein level, underlining the importance of investigating a broad 
range of molecular parameters. The fact that the liver also displayed a relative stable transcriptional 
expression, suggests toxicity adaptation in the organism as a whole. 
4.3 MeHg affects immunological response 
Compared to the effects on metabolic and oxidative stress, much less is known about the effects of 
MeHg on inflammation. The kidney is an important immunological organ in teleost fishes (Iwama et 
al., 1996), and, together with blood, have a higher abundance of immune related cells compared to 
other tissues normally investigated for MeHg toxicity, such as brain, liver or muscle. Therefore, the 
kidney and blood may provide a more sensitive response for immunological markers in our 
proteomic study. An effect of MeHg exposure was seen on the immune-related proteins LGALS2 and 
SERPINA7, possibly linking MeHg-exposure to immunological responses in Atlantic salmon kidney. In 
addition, differential regulation of the aforementioned HPX may be indicative of an immunological 
response (Bakker et al., 2010). Galectins are highly conserved in evolution (Rabinovich et al., 2002), 
confirmed by Blastx search which showed that the peptide sequence annotated to LGALS2 from 
salmon kidney had a 96% similarity against the human galectin 2 (LGALS2) protein. Human LGALS2 is 
normally expressed in the gastrointestinal system and in some tumors, and has been linked to the 
induction of apoptosis in T-cells (Sturm et al., 2004). Galectins show a high sequence similarity in the 
carbohydrate recognition domain (CRD) (Rabinovich et al., 2002), possibly indicating that the 
identified LGALS2 from salmon kidney may be homologous to another isoform of the galectin 
superfamily since the main hits in our Mascot search were in the CRD (controlled by ExPASy search). 
Either way, LGALS2 was differently regulated in kidney of the MeHg exposed fish, suggesting an 
immunological effect. 
The SERPINA7 in salmonids was first identified in rainbow trout seminal plasma (Mak et al., 2004). 
This protein showed high similarity to the mammalian serine protease inhibitor (serpin) family which 
are plasma proteins involved in several regulatory functions (Potempa et al., 1994). The main 
mammalian serine protease inhibitor in blood is the α-1-antiproteinase inhibitor (the equivalent 
version to the rainbow trout SERPINA7) of which the main function is to inhibit neutrophil elastase 
and thereby playing a possible anti-inflammatory role. In our study we identified a down-regulation 
of SERPINA7, indicating an inflammatory response to MeHg. 
4.4 Conclusion 
This is the first study investigating toxic effects of MeHg in the proteome of the Atlantic salmon 
kidney. MeHg increased the abundance of proteins related to oxidative stress in the kidney, as 
indicated by the increased abundance of GPX2 at the protein level. Several proteins involved in 
energy metabolism, especially mitochondrial energy metabolism, showed decreased abundance in 
response to MeHg exposure both at the transcriptional and the proteomic level. Oxidative stress and 
reduced energy metabolism are well-known toxicological markers of MeHg exposure, however, 
immunological effects have been less affiliated with MeHg treatment. The observed immunological 
effect of MeHg may be organ-dependent, and should be examined further in follow-up studies. 
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Figure captions 
Figure 1  
Representative 2-D gel. The positions of the spots excised from the gel are indicated by circle. 
Identities of these proteins are shown by lettering. 
Figure 2 
Mean normalized gene expression (MNE) of: (A) gapdh and (B) aco in liver from Atlantic salmon. Data 
represented by median, with boxes representing interquartile range, and whiskers representing total 
range. Significant differences are indicated through small letters (p < 0.05). Statistic analysis 
performed using the non-parametric Mann-Whitney U test. 
  
Tables 
Table 1. Hg content (mg kg-1) of fish exposed to 4 mg kg-1 MeHg in feed and control for 8 weeks. 
 MeHg exposed fish Control 
Kidney 2.96 ± 0.44 a 0.10 ± 0.02 b 
Liver 4.18 ± 1.19 a 0.06 ± 0.04 b 
Red Blood cells 7.12 ± 3.33 a 0.11 ± 0.05 b 
Plasma 0.21 ± 0.16 a 0.01 ± 0.02 b 
Data presented as median ± range. In kidney samples (N = 16), in liver (N =18), significant differences are indicated 
though superscript small letters (p < 0.05). Data were tested by non parametric Kruskal Wallis test and post hoc paired 
comparisons. 
 
  
Table 2. Q-PCR Primer pair information, all sequences are presented as 5´ to 3´. 
Gene Acession Fwd primer Rev. Primer amplicon 
size 
PCR 
efficiency 
ARP AY255630 GAAAATCATCCAATTGCTGGATG CTTCCCACGCAAGGACAGA 101 2.08a, 1.93b 
EF1Ab BG933853 TGCCCCTCCAGGATGTCTAC CACGGCCCACAGGTACTG 59 2.20a, 1.89b 
ACTB NM_001124235 GCCGCGACCTCACAGACTAC CAAAGTCCAGCGCCACGTA 126 2.12a, 2.09b 
Ubi BG936428 GATCTTCGCTGGCAAACAACT CGAAGACGCAGCACAAGATG 93 2.01a, 1.94b 
FATP CA373015/ 
AF023258 
TGGGAGCTTGTGGGTTCAA ACTTTCATGAGGCGGATTGG 64 Xa, 2.19b 
ACO DQ364432 CACTGCCAGGTGTGGTGGTA GGAATTGTACGTTCTCCAATTTCA 92 2.06a, 2.02b 
FABP3 AY509548 CACCGCTGACGACAGGAAA TGCACGTGAACCATCTTACCA 66 1.93a, 1.97b 
TUBA BT049768 GAGCCAGCCAATCAGATGGT TGCGCTTGGTCTTGATTGTG 110 2.05a, 1.98b 
GSH-PX BQ036408 TTCTCCACCACACTGGGATCA GGAAATGGCATCAAGTGGAATT 101 2.07a, 1.89b 
CPT1 AM230810 CTTTGGGAAGGGCCTGATC CATGGACGCCTCGTACGTTA 121 1.98a, 1.98b 
Bcl-X NM_001141086 GCCTGGACGCAGTGAAAGAG GGACGGCGTGATGTGTAGCT 107 1.10a, 2.16b 
CRC BT044674 CACCAAGAAGGTTCATGTCATC GTCTGGTCCGGGTTCAGGAT 123 2.08a, 2.11b 
Akr1B3 BT049670 TCTCTGCTCGAGGACCCAAA CGTAGCCGACTTGGGAATGA 120 2.08a, 1.99b 
GRP94 NM_00119500 CTGGGTACCATCGCCAAGTC CAACCAGGAAGGCGGAGTAG 130 2.19a, 2.19b 
Ferritin BT046912 CCGGATGATCAACATGGAGAT TCGTCGCTGTTCTCCTTGAA 120 2.00a, 1.87b 
14-3-3E1 BT045507 GATCCGGGAATACAGGCAAA GACCTTGGACTCTCCCGTGTT 115 2.02a, 2.05b 
ANXA 13 BT044880 GGGTCTGGCTGAAGCAGATG AGGTGGCCTGTAGCTGAAGGT 122 2.17a, 2.14b 
WAP 65 Z68112 GAGGTGGATGCCACCTTCTC TCCCAGCACCTCCTTCAAAG 132 2.02a, 2.02b 
GAPDH BT045621 CCACTCCATCTCCGTATTCCA TGGGAAGAGGCCTTGTCAAT 120 2.02a, 2.12b 
X denotes a non functional assay , superscript a denotes PCR efficiency in kidney, and superscript b denotes PCR 
efficiency in liver  
 
 
 
 
  
Ta
bl
e 
3.
  I
de
nt
ifi
ca
tio
n 
of
 si
gn
ifi
ca
nt
ly
 re
gu
la
te
d 
pr
ot
ei
ns
 b
y 
LC
 M
S/
M
S.
 
Le
tt
er
 
co
de
a 
id
en
tif
ic
at
io
n 
fo
ld
 
ch
an
ge
 
Sc
or
eb
 
kD
ac
 
PI
c 
Sp
ec
ie
s 
Se
q.
 
Co
ve
ra
ge
 (%
)d
 
M
at
ch
es
e 
Se
qu
en
ce
sf 
em
PA
Ig 
SE
RP
IN
A7
 
al
ph
a-
1-
an
tip
ro
te
in
as
e-
lik
e 
pr
ot
ei
n 
-1
.3
 
63
 
47
.6
7 
5.
86
 
O
. m
yk
iss
 
2 
2 
(1
) 
1(
1)
 
0.
07
 
SE
RP
IN
A7
 
al
ph
a-
1-
an
tip
ro
te
in
as
e-
lik
e 
pr
ot
ei
n 
-1
.3
 
63
 
47
.6
7 
5.
86
 
O
. m
yk
iss
 
2 
4(
1)
 
1(
1)
 
0.
07
 
AC
TB
 
be
ta
 a
ct
in
 
-1
.3
 
61
5 
42
.0
1 
5.
38
 
O
. m
yk
iss
 
39
 
28
(2
) 
14
(1
) 
 
GA
PD
H 
Gl
yc
er
al
de
hy
de
-3
-p
ho
sp
ha
te
 
de
hy
dr
og
en
as
e 
-1
.3
 
42
3 
36
.5
6 
6.
07
 
Sa
lm
o 
sa
la
r 
29
 
16
(4
) 
8(
4)
 
0.
68
 
GP
X2
 
gl
ut
at
hi
on
e 
pe
ro
xi
da
se
 2
 
1.
2 
13
6 
16
.5
3 
5.
93
 
O
. m
yk
iss
 
39
 
5(
0)
 
5(
0)
 
 
VS
P2
9 
va
cu
ol
ar
 p
ro
te
in
 s
or
tin
g 
as
so
ci
at
ed
 
pr
ot
ei
n 
29
 
-1
.2
 
25
9 
20
.6
 
6.
22
 
Sa
lm
o 
sa
la
r 
40
 
11
(1
) 
8(
1)
 
 
VS
P2
9 
va
cu
ol
ar
 p
ro
te
in
 s
or
tin
g 
as
so
ci
at
ed
 
pr
ot
ei
n 
29
 
-1
.3
 
 
 
 
Sa
lm
o 
sa
la
r 
 
 
 
 
HS
P9
0A
B
1 
he
at
 
sh
oc
k 
90
 
pr
ot
ei
n 
1 
be
ta
 
iso
fo
rm
 a
 
-1
.3
 
15
0 
83
.6
1 
 
Sa
lm
o 
sa
la
r 
6 
5(
1)
 
4(
1)
 
 
HP
X 
he
m
op
ex
in
 li
ke
 p
ro
te
in
 
-1
.3
 
12
6 
51
.1
1 
5.
61
 
O
. m
yk
iss
 
 
3(
1)
 
2(
1)
 
0.
06
 
HS
PD
1 
60
 k
Da
 h
ea
t s
ho
ck
 p
ro
te
in
 
-1
.2
 
19
3 
61
.3
3 
5.
62
 
Sa
lm
o 
sa
la
r 
18
 
7(
0)
 
6(
0)
 
0.
05
 
LG
AL
S2
 
ga
le
ct
in
 2
 
1.
2 
19
7 
14
.8
8 
5.
93
 
Sa
lm
o 
sa
la
r 
52
 
6(
1)
 
4(
1)
 
1.
28
 
HP
X 
he
m
op
ex
in
 li
ke
 p
ro
te
in
 
-1
.5
 
15
5 
51
.1
1 
5.
61
 
O
. m
yk
iss
 
5 
5(
1)
 
2(
1)
 
0.
06
 
HP
X 
he
m
op
ex
in
 li
ke
 p
ro
te
in
 
-1
.4
 
13
9 
51
.1
 
5.
61
 
Sa
lm
o 
sa
la
r 
8 
3(
1)
 
3(
1)
 
0.
06
 
AT
PB
5 
AT
P 
sy
nt
ha
se
 
H+
 
tr
an
sp
or
tin
g 
m
ito
ch
on
dr
ia
l F
1 
co
m
pl
ex
 b
et
a  
1.
1 
67
 
52
.9
1 
4.
87
 
Sa
lm
o 
sa
la
r 
10
 
3(
0)
 
3(
0)
 
 
Th
e 
su
pe
rs
cr
ip
ts
 g
iv
en
 in
 th
e 
ta
bl
e 
de
no
te
s:
 
a  C
od
e 
gi
ve
n 
to
 e
ac
h 
pr
ot
ei
n 
is
 b
as
ed
 o
n 
hu
m
an
 b
as
ed
 ID
s o
bt
ai
ne
d 
fr
om
 w
w
w
.g
en
ec
ar
ds
.c
om
, t
he
se
 id
en
tit
ie
s w
er
e 
us
ed
 a
s i
np
ut
 in
 th
e 
pa
th
w
ay
 a
na
ly
se
s.
  
b  S
co
re
s 
ar
e 
ge
ne
ra
te
d 
th
ro
ug
h 
au
to
m
at
ic
 c
al
cu
la
tio
n 
by
 th
e 
m
as
co
t s
ea
rc
h 
en
gi
ne
 b
as
ed
 o
n 
M
O
W
SE
 s
co
re
s 
(P
ap
pi
n 
et
 a
l.,
 1
99
3)
, s
co
re
s 
gr
ea
te
r t
ha
n 
60
 in
 th
e 
N
CB
I d
at
ab
as
e 
ar
e 
de
em
ed
 
si
gn
ifi
ca
nt
 (p
 <
 0
.0
5)
.  
c  B
ot
h 
w
ei
gh
t (
kD
a)
 a
nd
 P
I o
f t
he
 p
ro
te
in
s a
re
 g
iv
en
 a
s t
he
or
et
ic
al
 v
al
ue
s p
ro
vi
de
d 
fr
om
 th
e 
N
CB
I d
at
ab
as
e.
 
d  P
er
ce
nt
ag
e 
of
 th
e 
se
qu
en
ce
 c
ov
er
ed
 b
y 
id
en
tif
ie
d 
pe
pt
id
es
.  
 
e  M
at
ch
es
 in
di
ca
te
s t
he
 n
um
be
r o
f M
S/
M
S 
sp
ec
tr
a 
m
at
ch
ed
 to
 th
is
 p
ro
te
in
 (n
um
be
rs
 in
 b
ra
ck
et
s 
de
no
te
 si
gn
ifi
ca
nt
 m
at
ch
es
). 
 
f  S
eq
ue
nc
es
, c
ou
nt
 o
f d
ist
in
ct
 p
ep
tid
es
 m
at
ch
ed
 (n
um
be
rs
 in
 b
ra
ck
et
s d
en
ot
e 
si
gn
ifi
ca
nt
 se
qu
en
ce
s)
.  
 
g  E
xp
on
en
tia
lly
 M
od
ifi
ed
 P
ro
te
in
 A
bu
nd
an
ce
 In
de
x 
(e
m
PA
I) 
is
 a
 re
la
tiv
e 
qu
an
tit
at
io
n 
of
 th
e 
pr
ot
ei
n 
in
 th
e 
sp
ec
ifi
c 
sp
ot
 (I
sh
ih
am
a 
et
 a
l.,
 2
00
5)
.  
 
Table 4. Mean normalized gene expression (MNE) and range (presented in brackets) of transcripts analyzed in kidney and 
liver of Atlantic salmon. 
 Kidney Liver 
Gene  Ctr MeHg Ctr MeHg 
GPX2  0.65 ± (0.28) 0.72 ± (0.21) 0.58 ± (0.85) 0.65 ± (0.60) 
Ferritin  0.78 ± (0.39) 0.89 ± (0.38) 0.81 ± (0.83) 0.78 ± (0.20) 
WAP 65  0.64 ± (0.46) 0.63 ± (0.48) 0.57 ± (0.50) 0.55 ± (0.36) 
GAPDH  0.63 ± (0.39) 0.71 ± (0.38) 0.67 ± (0.44)* 0.50 ± (0.39) 
14-3-3E1  0.69 ± (0.44) 0.70 ± (0.27) 0.78 ± (0.23) 0.85 ± (0.55) 
Akr1B3  0.54 ± (0.93) 0.40 ± (0.20) 0.46 ± (0.75) 0.34 ± (0.38) 
ACO  0.57 ± (0.51) 0.51 ± (0.37) 0.54 ± (0.48)* 0.38 ± (0.50) 
ARP  0.66 ± (0.43) 0.68 ± (0.22) 0.55 ± (0.39) 0.41 ± (0.33) 
ANXA 13  0.57 ± (0.43) 0.64 ± (0.27) Ref gene Ref gene 
GRP94  0.67 ± (0.25) 0.73 ± (0.28) Ref gene Ref gene 
TUBA  0.76 ± (0.19) 0.80 ± (0.38) Ref gene Ref gene 
FABP3  0.79 ± (0.25) 0.70 ± (0.47) Ref gene Ref gene 
CRC  0.72 ± (0.34) 0.75 ± (0.60) Ref gene Ref gene 
BclX  0.75 ± (0.24) 0.75 ± (0.49) Ref gene Ref gene 
ACTB  0.56 ± (0.31) 0.64 ± (0.52) Ref gene Ref gene 
Ubi  0.76 ± (0.22) 0.79 ± (0.27) Ref gene Ref gene 
FATP  N. D. N. D. 0.70 ± (0.43) 0.52 ± (0.65) 
  * denotes significantly regulated transcripts (the significantly differentially regulated transcripts are also shown in figure 
2) N. D. denotes not detected in q-PCR. 
 
  
Supplementary table. Top biological functions affected on a proteomic level by MeHg in kidney of Atlantic salmon  
IPA tox analysis  
Top networks Scorea 
Carbohydrate metabolism, energy production, nucleic acid metabolism 11 
Cellular function and maintenance, embryonic development, tissue morphology 2 
Top Tox Lists   
Name           p-valueb Ratioc 
NRF2-mediated Oxidative Stress Response 4.06E-03 0.013 
Increases renal proliferation 2.13E-02 0.032 
Hypoxia-Inducible Factor signaling 3.62E-02 0.019 
Mechanism of gene regulation by peroxisome proliferators via PPARα 5.48E-02 0.012 
Mitochondrial Dysfunction 6.54E-02 0.01 
Top bio functions   
Name p-valueb Moleculesd 
Diseases and Disorders 
Inflammatory disease 6.92E-04 - 1.99E-02 2 
Neurological disease 6.92E-04 - 3.21E-02 3 
Ophtalmic disease 6.92E-04 - 6.92E-04 1 
Infection mechanism 1.38E-03 - 1.51E-02 3 
Inflammatory response 2.08E-03 - 3.08E-02 1 
Molecular and cellular functions 
Protein synthesis 3.42E-04 - 9.66E-03 2 
Post-translational modification 5.21E-04 - 6.91E-03 2 
Protein folding 5.21E-04 - 6.91E-03 2 
Cellular function and maintenance 6.24E-04 - 3.15E-02 4 
Carbohydrate  6.92E-04 - 2.06E-02 1 
Physiological system development and function 
Organ development 1.38E-03 - 3.15E-02 1 
Reproductive system development and function 1.38E-03 - 3.15E-02 1 
Hematological system development and function 2.08E-03 - 3.08E-02 2 
Immune cell trafficking 2.08E-03 - 3.08E-02 1 
Cardiovascular system development and function 4.15E-03 - 1.38E-02 1 
Letters in superscript annotate:  
a: Score denotes how well a given network relate to the proteins in question. Networks indicates what other proteins 
could be affected by the proteins regulated in the study, and what biological mechanisms this can be related to.  
b: p-value in IPA is calculated using right tailed Fishers Exact test. The p-value indicates how likely it is that associations 
between these proteins happen by chance.  
c: ratio is calculated by dividing network proteins on the number of total proteins in that particular toxic pathway   
d: molecules denotes how many proteins are involved in this specific function.   
  
 Figure 1 
  
M
N
E
Ct
r
Me
Hg
0.0
0.2
0.4
0.6
0.8
1.0
a
b
M
N
E
ctr
Me
Hg
0.0
0.2
0.4
0.6
0.8
1.0
a
b
A
B
 
 Figure 2 
